A replacement shipment is not an investigation.
Use this gummy supplement complaint and out-of-specification response checklist to connect the reported issue to containment, relevant batches, original evidence, disposition, follow-up action and a documented buyer decision.
The closeout question is not “did the supplier answer?”
Ask whether the response identifies the right product and batches, preserves the original evidence, explains the scope and decision, records approvals and leaves a traceable follow-up path. Commercial credit, replacement product and quality disposition are separate decisions.
The six-stage response evidence chain
Intake
Complaint, product, lot, dates, use, condition, reporter and available sample.
Contain
Hold, shipment stop, return control, sample preservation and escalation.
Scope
Specifications, related batches, components, packaging, markets and records.
Investigate
Original data, methods, production history, distribution and hypotheses.
Decide
Finding, material review, disposition, market action and customer response.
Follow up
Action owner, completion evidence, effectiveness, trend and closure approval.
First classify the event correctly
Product complaint
A communication alleging concern with supplement quality that could relate to CGMP. It may arrive orally, electronically or in writing.
OOS result
Operational shorthand on this page for a result outside an approved specification. Part 111 does not supply one universal “OOS procedure” by that name.
Deviation
A departure from the master record, required step, specification or another controlled requirement. It may be found before any complaint occurs.
Returned product
Physical product returned into the responsible operation. It requires identification and quarantine pending material review and disposition.
These categories can overlap but are not substitutes. A potency complaint may generate a laboratory result and a returned sample. A seal defect may reveal a packaging deviation without an OOS test. A customer refund does not determine whether other batches or records are relevant.
Twelve checks before accepting a supplier closeout
1. Identify the complaint and product
- Complaint/case ID and receipt date
- Product name, form, count and market
- Batch, lot or control number if available
- Manufacture, distribution and best-by dates where relevant
2. Preserve the reporter's facts
- Original wording and communication channel
- How the product was used or stored, if known
- Photographs, receipt and package condition
- Reporter contact and reply record where available
3. Secure the sample and data
- Returned unit, reserve sample or retained evidence
- Seal, custody, receipt condition and storage
- Unaltered laboratory raw data and calculations
- Original result, not only a later summary
4. Document immediate controls
- Inventory, work-in-process and component status
- Shipment hold or distribution review where justified
- Related testing or record preservation
- Who made each interim decision and when
5. Name the governing requirement
- Approved product, component, package or label specification
- Master-record or process requirement
- Method, unit, sampling basis and acceptance criterion
- Customer or market requirement kept distinct
6. Review the original test context
- Sample identity, selector and representativeness
- Method/reference, revision and gummy-matrix suitability
- System suitability, standards, preparation and calculations
- Laboratory identity and applicable competence scope
7. Extend to relevant batches and records
- Same component, packaging or label lots
- Adjacent or campaign batches
- Same equipment, line, method, analyst or supplier
- Prior complaints, deviations, returns and stability signals
8. Reconstruct manufacturing history
- Master and executed batch-record revisions
- Component and packaging identifiers
- Monitoring, yield, line, sanitation and release evidence
- Distribution scope tied to the affected lot
9. Separate fact, hypothesis and root cause
- Confirmed observations and source records
- Hypotheses tested and results
- Assignable cause only when supported
- “No cause found” recorded honestly when unresolved
10. Record material review and disposition
- Trigger and affected material/product
- Quality review and decision at time of performance
- Reject, treatment, adjustment, reprocess or other disposition basis
- Release prohibited until applicable requirements are met
11. Define follow-up action
- Correction versus systemic corrective/preventive action
- Action owner, due date and completion evidence
- Change-control and requalification effects
- Effectiveness or trend review appropriate to the finding
12. Close all decisions explicitly
- Quality disposition and approver
- Customer response, credit or replacement decision
- Market, distribution or regulatory assessment
- Open monitoring, due dates and closure authority
Issue-to-evidence matrix
| Issue signal | Immediate evidence to preserve | Scope questions | Decision evidence |
|---|---|---|---|
| Potency or composition OOS | Original sample, method, raw data, calculations, standard/preparation and report | Same batch, component lots, method, laboratory, related batches and stability time points | Data review, investigation finding, specification comparison, material review and disposition |
| Microbiological or foreign-material concern | Unopened/returned unit, images, custody, package condition and distribution information | Same batch, environment, components, equipment, sanitation, packaging and other complaints | Qualified risk assessment, containment, investigation, disposition and market-action decision |
| Wrong label, count or product | Actual package, label/code photographs, order and distribution records | Label/component issuance, reconciliation, line clearance, vision/reject controls and affected lots | Traceability, investigation, inventory/distribution reconciliation and approved action |
| Texture, odor, flavor or appearance | Product/sample condition, storage history, dates, images and sensory description | Formula, process, package, transport, stability, season, component lots and complaint trend | Criteria or controlled reference, investigation limits, disposition and monitoring |
| Seal, closure or package failure | Package configuration, lot, seal/closure condition, handling and photos | Component lots, line settings, first-batch checks, transport and packaging changes | Specification review, package examinations, affected scope and corrective action |
| Returned product | Return reason, product identity, lot, condition, custody and quarantine status | Whether the reason implicates other batches or manufacturing processes | Material review, disposition, any testing, other-batch investigation and release/rejection evidence |
Retest is evidence—not a reset button
A supplier response may lead with a passing repeat result. That result can be relevant, but it does not explain why the original result occurred. Before using any repeat test to make a decision, ask:
- Was the original sample and raw data preserved and reviewed before additional testing?
- Was a documented laboratory or sampling cause found, or is it only suspected?
- Did the repeat test use the same sample, a resample, a reserve sample or a different batch?
- Were method, preparation, analyst, laboratory, unit or reporting basis changed?
- Was the number and selection of repeat tests defined before seeing the new results?
- How are all results reported, reconciled and connected to the final disposition?
Part 111 requires quality review and disposition when applicable specifications are not met; it does not provide a generic buyer rule that a later passing value automatically invalidates an earlier one. The scientifically supportable conclusion belongs in the investigation record, with its scope and limitations.
What Part 111 connects
- Specifications not met: 21 CFR 111.77 addresses rejection and limited quality-control-approved treatment, in-process adjustment or reprocessing pathways for specified categories; finished batches cannot be released unless applicable release requirements are met.
- Material review: 21 CFR 111.113 requires quality-control material review and disposition when a specification is not met, a batch deviates from the master record, an unanticipated occurrence may affect the product or packaging, calibration suggests a batch-quality problem, or a supplement is returned.
- Returned product: 21 CFR 111.510 requires returned supplements to be identified and quarantined pending material review and disposition. Section 111.530 extends an investigation to manufacturing processes and other batches when the return reason implicates them.
- Complaint review: 21 CFR 111.560 requires a qualified person to review all product complaints and investigate those involving a possible Part 111 or specification failure. Quality control reviews decisions, findings and follow-up, and the scope extends to all relevant batches and records.
- Complaint records: 21 CFR 111.570 identifies written-procedure and complaint-record fields, including product description, lot if available, receipt/reporter information if available, complaint nature, reply if any, and investigation findings/follow-up when performed.
Copy-ready supplier investigation request
Buyer closeout gate
Do not close the commercial record merely because a replacement, credit or short email arrived. Record four separate decisions:
- Quality decision: what the investigation and applicable disposition support for the affected product and batches.
- Supply decision: whether production, shipment or sourcing can continue under defined conditions.
- Market decision: whether distributed product, customers, retailers or authorities require action.
- Commercial decision: credit, replacement, cost allocation and contract follow-up.
If any owner, due date or evidence remains open, mark the case conditionally closed or open rather than silently treating the investigation as final.
Related procurement tools
Label & Artwork Release
Match the complaint lot to the approved copy, artwork revision and label-use evidence.
Check the revision →Laboratory Report Review
Check sample, method, specification, unit, laboratory scope and result limits.
Review the report →COA & Batch Records
Separate component, production, finished-product and stability evidence.
Map the records →Project Evidence Register
Track source files, scope, status, owners and disclosure rights.
Open register →FDA Gummy Enforcement Data
Review six event-level supplement-gummy records and the controls they support.
Audit the data →Primary sources and scope
- 21 CFR 111.77 — specifications not met
- 21 CFR 111.113 — material review and disposition
- 21 CFR 111.510 — returned-product identification and quarantine
- 21 CFR 111.530 — investigation of processes and other batches
- 21 CFR 111.560 — product complaint review and investigation
- 21 CFR 111.570 — product complaint records
- FDA — Dietary Supplement CGMP Small Entity Compliance Guide
Scope note: this page is educational procurement guidance, not legal, scientific, recall or medical advice. It does not represent a Sucotond complaint, OOS result, root cause, corrective action or product disposition. Qualified quality, regulatory, safety and legal personnel should review the actual event and applicable market obligations.
Turn a supplier answer into a decision-ready record.
Share non-confidential product, batch, specification, report and response details. Sucotond USA can coordinate an internal project review; evidence availability, responsibilities and any next steps are confirmed for the specific case.
Request Project Review